Forex Education Symbols

76.50 -3.50 (-4.38%) 10/18/2017 4:30pm
Open: 70.00 Prev Close: 80.00
High: 83.00 Low: 70.00
Volume: 12555 Market Cap: 6.81M
Year High: 255.00 Year Low: 64.93
Stock Technical Analysis
Targets Six months: 97.55    One year: 110.96
Supports Support1: 64.93   Support2: 54.03
Resistances Resistance1: 83.52    Resistance2: 95.00 
Pivot Point 76.43 
Moving Averages MA(5): 79.30      MA(20): 76.07 

MA(100): 87.67      MA(250): 121.408 
MACD MACD(12,26): 0.56      Signal(12,26,9): 0.02 
Stochastic Oscillator %K(14,3): 30.33      %D(3): 28.44 
RSI RSI(14): 48.23 
52-Week High: 255.00  Low: 64.93  Change(%): -67.4
Average Volume(K) 3-Month: 43  10-Days: 1.560700
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
AKR.L has closed below upper band by 49.2%. Bollinger Bands are 17.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
A Head-to-head Comparison of Akers Biosciences, Inc. (AKER) and Dextera ...
Wed, 18 Oct 2017 12:45:00 GMT

Akers Biosciences' (AKER) CEO John Gormally on Q1 2017 Results - Earnings Call ...
Tue, 16 May 2017 16:22:08 GMT

Akers Biosciences Inc.
Fri, 24 Jan 2014 08:36:07 GMT

Directionless Akers Biosciences Inc (NASDAQ:AKER)
Mon, 16 Oct 2017 21:33:45 GMT

Akers Biosciences' (AKER) CEO John Gormally on Q2 2017 Results - Earnings Call ...
Tue, 15 Aug 2017 17:15:00 GMT

Another motive To buy these stock: Akers Biosciences, Inc. (AKER), RPM ...
Fri, 13 Oct 2017 12:11:15 GMT

Stoxline Canada

Stock Chart London

Option Calculator

EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M)
Shares Float (M)
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
P/E Growth Ratio
P/CF 36.48